Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.
about
Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare DataCyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisThe role of obesity in oesophageal cancer development.Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagusPathophysiological mechanisms linking obesity and esophageal adenocarcinomaAssociation between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control studyNonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.Aspirin chemoprevention in barrett esophagus: is the risk worth the benefit?Management strategies of Barrett's esophagusOperable gastro-oesophageal junctional adenocarcinoma: Where to next?Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.Risk factors for Barrett's esophagus: a scoping review.Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment.Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus.Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis.Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking.Optimization and expansion of predictive models for Barrett's esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial?Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis.Medical Prevention of Barrett's Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins.Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.Aspirin Use is Associated With Lower Risk of Barrett’s Esophagus in Women.Association of sporadic and familial Barrett's esophagus with breast cancer.Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.Aspirin: the miracle drug?
P2860
Q30786254-38368D7E-4E98-4605-8CE7-C6C907F6D5B7Q33555216-29F384B3-CDA2-444B-9126-0DE308A625CCQ34418740-20170C3B-82E3-4DCA-985C-9D059FAFBA73Q34429198-F0335675-852B-4B71-B91E-9E261314483DQ34508880-269BEEE2-D791-4CA3-A55C-DBBD2D96C25FQ35000054-200A7561-DC7B-4501-AC2E-10EB69A0BC4CQ35007536-DCEEDFE8-F15B-45B5-B70A-5C017CFB0CD3Q35619274-DA70E490-5A52-4FC7-BDDC-908AAD2D01A4Q37398529-A3412CB2-F4B9-426D-83A1-920E1E06585FQ37505223-7FCB5C0A-1382-4C05-85AB-B52A82CD1E2DQ37554702-368AFE27-7025-4962-983E-241644B57CD3Q37677891-986AA537-4FD9-4B40-9179-84FFF98BAEC8Q38062526-268FCB23-3260-4B6D-9071-179F74777C2EQ38220816-C05C9981-33F1-4C30-B051-546BE72F18F0Q38332589-D61885D3-1E0F-4F6B-A5C1-C108B38A6C08Q38368081-68872A93-101A-44DD-89D0-E5609450BFCFQ38723616-0C09D20F-182D-4ABC-A64C-7E7D4973B795Q39550675-A4A19BD2-39A0-42A1-80FF-1F5F2436902CQ40516702-7E94888B-C588-4358-BD34-7CF1CBCC074AQ40522077-8B8C139D-0F2E-406E-85C8-1066AA27457EQ46044763-9BF5CF61-9CEA-43F3-9606-8B6B8504C9C5Q46087987-C203579E-1725-4A48-AD6A-7B626931E368Q47229243-F7DB3544-45F8-4F27-B201-1A1A67137D63Q47810183-65F893FA-1438-4F84-826B-38380BF59035Q48115635-4A91BED8-16DF-4781-973F-0B4AD6512090Q48233200-74C79647-9141-469D-9707-B4033EF9D1A6Q49227522-B6A9AA20-04C8-4A86-A29E-D8739716DBA5Q52661117-A8BC09B3-3B0E-4AC1-83E8-B90CAC15075DQ54889608-532288F6-BDB9-4FC8-99E5-7CB7CE59D5E9Q55395319-B9FEA7EB-D8DF-4649-A30B-8216FD40C3AA
P2860
Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Aspirin protects against Barre ...... logistic regression analysis.
@ast
Aspirin protects against Barre ...... logistic regression analysis.
@en
type
label
Aspirin protects against Barre ...... logistic regression analysis.
@ast
Aspirin protects against Barre ...... logistic regression analysis.
@en
prefLabel
Aspirin protects against Barre ...... logistic regression analysis.
@ast
Aspirin protects against Barre ...... logistic regression analysis.
@en
P2093
P2860
P1476
Aspirin protects against Barre ...... logistic regression analysis.
@en
P2093
Ashwin N Ananthakrishnan
Chung Yin Kong
Elisabeth B Cole
Jesse J Lin
Kevin J Nattinger
Zehra B Omer
P2860
P304
P356
10.1016/J.CGH.2012.02.031
P407
P577
2012-03-15T00:00:00Z